A world-renown cardiac researcher and former Harvard Medical School professor has been accused of fabricating or falsifying the data in 31 of his published studies.
Piero Anversa is an Italian-born researcher who rose to fame in the early 2000s after publishing pioneering studies on the regeneration of the heart tissue by stem cells. Anversa moved to Harvard Medical School and Brigham and Women’s Hospital in 2007, and was appointed a full professor in 2010.
But Anversa left Harvard in 2015 after questions were raised about the veracity of his research. Now, officials from Harvard Medical School and Brigham and Women’s Hospital in Boston have recommended that that 31 papers from a former lab director be retracted from journals. The papers “included falsified and/or fabricated data,” according to a statement to Retraction Watch and STAT from the two institutions.
Last year, the hospital agreed to a US$10 million settlement with the US government over allegations Anversa and two colleagues’ work had been used to fraudulently obtain federal funding. Stem cell researchers at other labs around the US have routinely failed to replicate Anversa’s results.
Some researchers have welcomed the investigation into Anversa’s research, saying that the idea of regenerative stems cells existing in the heart is implausible. “It really is a relief that this has been corrected”, said Jeffery Molkentin, a researcher at Cincinnati Children’s whose lab was among the first to question the basis of Anversa’s results in a 2014 paper in Nature. “There are no stem cells in the heart. Quit trying to publish those results”.
Experts have expressed concern that a clinical trial based on Anversa’s research is continuing to recruit patients.
This article is published by
and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines
. If you teach at a university we ask that your department make a donation. Commercial media must contact us
for permission and fees. Some articles on this site are published under different terms.